Datta, S., Soldano, K., Silas, D. P., Li, G., Nystrom, S., Garrett, M. E., … Olabisi, O. A. (2024). Potentiated JAK-STAT Signaling Differentiates Stem Cell-Derived Podocytes of Patients with APOL1-Associated FSGS from Those of Healthy Carriers with a High-Risk APOL1 Genotype. In Journal of the American Society of Nephrology (Vol. 35). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1681/asn.2024vcvq40fd

Datta, Somenath, Karen Soldano, Daniel Philip Silas, Guojie Li, Sarah Nystrom, Melanie E. Garrett, Allison Ashley-Koch, and Opeyemi A. Olabisi. “Potentiated JAK-STAT Signaling Differentiates Stem Cell-Derived Podocytes of Patients with APOL1-Associated FSGS from Those of Healthy Carriers with a High-Risk APOL1 Genotype.” In Journal of the American Society of Nephrology, Vol. 35. Ovid Technologies (Wolters Kluwer Health), 2024. https://doi.org/10.1681/asn.2024vcvq40fd.

Datta S, Soldano K, Silas DP, Li G, Nystrom S, Garrett ME, et al. Potentiated JAK-STAT Signaling Differentiates Stem Cell-Derived Podocytes of Patients with APOL1-Associated FSGS from Those of Healthy Carriers with a High-Risk APOL1 Genotype. In: Journal of the American Society of Nephrology. Ovid Technologies (Wolters Kluwer Health); 2024.

Datta, Somenath, et al. “Potentiated JAK-STAT Signaling Differentiates Stem Cell-Derived Podocytes of Patients with APOL1-Associated FSGS from Those of Healthy Carriers with a High-Risk APOL1 Genotype.” Journal of the American Society of Nephrology, vol. 35, no. 10S, Ovid Technologies (Wolters Kluwer Health), 2024. Crossref, doi:10.1681/asn.2024vcvq40fd.

Datta S, Soldano K, Silas DP, Li G, Nystrom S, Garrett ME, Ashley-Koch A, Olabisi OA. Potentiated JAK-STAT Signaling Differentiates Stem Cell-Derived Podocytes of Patients with APOL1-Associated FSGS from Those of Healthy Carriers with a High-Risk APOL1 Genotype. Journal of the American Society of Nephrology. Ovid Technologies (Wolters Kluwer Health); 2024.